HOTAIR promotes paclitaxel resistance by regulating CHEK1 in ovarian cancer

被引:0
作者
Jiahong Jiang
Shaohai Wang
Zehua Wang
Jing Cai
Lingling Han
Lisha Xie
Qing Han
Wenwen Wang
Yifan Zhang
Xiaoqi He
Chun Yang
机构
[1] Huazhong University of Science and Technology,Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College
来源
Cancer Chemotherapy and Pharmacology | 2020年 / 86卷
关键词
CHEK1; Drug resistance; HOTAIR; Ovarian cancer; Paclitaxel;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:295 / 305
页数:10
相关论文
共 115 条
[11]  
Yuan Z(2018)Knockdown of long non-coding RNA HOTAIR increases cisplatin sensitivity in ovarian cancer by inhibiting cisplatin-induced autophagy J BUON 23 1396-1401
[12]  
Tang Q(2009)Doxorubicin and paclitaxel-loaded lipid-based nanoparticles overcome multidrug resistance by inhibiting P-glycoprotein and depleting ATP Cancer Res 69 3918-3926
[13]  
Hann SS(2015)TXNDC17 promotes paclitaxel resistance via inducing autophagy in ovarian cancer Autophagy 11 225-238
[14]  
Wu Y(2007)Weakened spindle checkpoint with reduced BubR1 expression in paclitaxel-resistant ovarian carcinoma cell line SKOV3-TR30 Gynecol Oncol 105 66-73
[15]  
Xiong Q(2001)Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) method Methods 25 402-408
[16]  
Li S(2010)An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients Breast Cancer Res Treat 123 725-731
[17]  
Cheng C(2005)Novel indication for cancer therapy: Chk1 inhibition sensitizes tumor cells to antimitotics Int J Cancer 115 528-538
[18]  
Qin Y(2012)Therapeutic strategies in epithelial ovarian cancer J Exp Clin Cancer Res 31 14-S2-16
[19]  
Zhi Q(1997)Comparison of combination therapy with paclitaxel and cisplatin versus cyclophosphamide and cisplatin in patients with suboptimal stage III and stage IV ovarian cancer: a Gynecologic Oncology Group study Semin Oncol 24 S2-13-2755
[20]  
Ozes AR(2016)LncRNA HOTAIR enhances ER signaling and confers tamoxifen resistance in breast cancer Oncogene 35 2746-216